Skip to main content
. 2019 Jul 30;29(5):714–721. doi: 10.1093/icvts/ivz153

Table 1:

Preoperative patients’ characteristics

Variables Uniportal group (n = 172) Three-portal group (n = 1808) P-value
Sex (male), n (%) 89 (59.7) 989 (54.7) 0.507
Age (years), median (IQR) 69.5 (11.3) 68.0 (12.0) 0.002
Charlson index, median (IQR) 4 (3) 4 (2) <0.001
FEV1%, median (IQR) 92.0 (25.9) 96.0 (27) 0.161
Tiffeneau, median (IQR) 75.6 (15.5) 76.7 (13.0) 0.081
COPD, n (%) 20 (11.6) 310 (17.1) 0.080
Diabetes, n (%) 27 (13.0) 203 (11.2) 0.623
Coronary disease, n (%) 14 (8.1) 159 (9.0) 0.881
ECOG score, median (IQR) 0 (1) 0 (0) 0.111
CT scan T dimension (cm), n (%)
 <2 87 (50.6) 951 (52.4) 0.669
 2–3 53 (30.8) 521 (28.7) 0.643
 3–5 31 (18.0) 298 (16.4) 0.681
 5–7 1 (0.6) 37 (2.0) 0.295
 >7 0 (0.0) 1 (0.05) 0.999
Clinical nodal involvement, n (%) 14 (8.1) 86 (4.8) 0.079
PET scan SUV, median (IQR) 4 (5) 3 (7) 0.024
Right side, n (%) 110 (64.0) 1123 (62.1) 0.694
Lobectomy types, n (%)
 Right upper lobectomy 60 (34.8) 632 (34.9) 0.999
 Right middle lobectomy 8 (4.7) 157 (8.7) 0.092
 Right lower lobe 37 (21.4) 318 (17.6) 0.238
 Upper bilobectomy 5 (3.0) 9 (0.5) 0.001
 Lower bilobectomy 0 (0) 7 (0.4) 0.885
 Left upper lobectomy 29 (16.9) 378 (20.9) 0.248
 Left lower lobectomy 33 (19.2) 307 (17.0) 0.531
Adenocarcinoma, n (%) 128 (74.5) 1330 (73.6) 0.878
Squamocellular carcinoma, n (%) 19 (11.0) 228 (12.6) 0.637
Other histology, n (%) 25 (14.5) 250 (13.8) 0.888
Epidural catheter, n (%) 11 (6.4) 475 (26.3) <0.001
Intercostal block, n (%) 148 (86) 932 (51.5) <0.001
Elastomeric pump, n (%) 34 (19.8) 684 (37.8) <0.001
Pericostal catheter, n (%) 0 (0.0) 104 (5.7) 0.002

CT: computed tomography; COPD: chronic obstructive pulmonary disease ; ECOG: eastern cooperative oncology group; FEV1: forced expiratory volume in 1 second; IQR: interquartile range; PET: positron emission tomography; SUV: standardized uptake value.